Literature DB >> 8706318

ACTH independent Cushing's syndrome occurring in siblings.

S Minami1, H Sugihara, J Sato, A Tatsukuchi, Y Sugisaki, H Sasano, I Wakabayashi.   

Abstract

Familial Cushing's syndrome due to ACTH independent bilateral macronodular adrenocortical hyperplasia occurring in siblings is reported. The proband was a 69-year-old woman who presented with a typical Cushingoid appearance. The serum cortisol level was elevated, with a loss of diurnal rhythm, and the plasma ACTH level was undetectable. Dynamic testing showed no suppression of urinary 17-OHCS by high dose dexamethasone and no stimulation by metyrapone. An abdominal CT scan showed bilateral adrenal enlargement. The patient died of a subarachnoid haemorrhage, and autopsy revealed a massively thickened adrenal cortex composed of nodules up to 3.5 cm in diameter. A pituitary adenoma was not found. We learned that the patient's elder brother was also diagnosed at 59 years of age with Cushing's syndrome due to bilateral macronodular adrenocortical hyperplasia. His plasma cortisol levels were not suppressed by high dose dexamethasone and the plasma ACTH level was undetectable. Screening of the available family members by administering 1 mg dexamethasone at midnight and performing abdominal CT scan revealed impaired suppressibility of serum cortisol associated with enlarged bilateral adrenal glands in a 64-year-old sister and a 54-year-old brother. The 64-year-old sister was considered as a possible 'affected' case in the early stages of development, because the basal level of ACTH was not suppressed and hyperplasia of the bilateral adrenal glands as revealed by CT scan was less evident.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8706318     DOI: 10.1046/j.1365-2265.1996.682504.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.

Authors:  Nobuhiro Miyamura; Tetsuya Taguchi; Yusuke Murata; Kayo Taketa; Shinsuke Iwashita; Kazuya Matsumoto; Takeshi Nishikawa; Tetsushi Toyonaga; Michiharu Sakakida; Eiichi Araki
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

2.  Cushing's syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia.

Authors:  M Terzolo; A Boccuzzi; A Ali; E Bollito; C De Risi; P Paccotti; A Angeli
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

Review 3.  Aberrant expression of hormone receptors in adrenal Cushing's syndrome.

Authors:  Stavroula Christopoulos; Isabelle Bourdeau; André Lacroix
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

4.  Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: progression of tumorigenesis in a disorder associated with multiple benign lesions.

Authors:  Madson Q Almeida; Michelle Harran; Eirini I Bimpaki; Hui-Pin Hsiao; Anelia Horvath; Chris Cheadle; Tonya Watkins; Maria Nesterova; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2011-01-20       Impact factor: 5.958

5.  Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma.

Authors:  Ulf Elbelt; Alessia Trovato; Michael Kloth; Enno Gentz; Reinhard Finke; Joachim Spranger; David Galas; Susanne Weber; Cristina Wolf; Katharina König; Wiebke Arlt; Reinhard Büttner; Patrick May; Bruno Allolio; Jochen G Schneider
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

6.  ARMC5 mutation in a Portuguese family with primary bilateral macronodular adrenal hyperplasia (PBMAH).

Authors:  Teresa Rego; Fernando Fonseca; Stéphanie Espiard; Karine Perlemoine; Jérôme Bertherat; Ana Agapito
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-03-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.